Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Cisplatin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Chemical compound and pharmaceutical drug}} {{redirect|Cisplatine|the Brazilian province that existed from 1821 to 1828|Cisplatina|the conflict in that province|Cisplatine War}} {{cs1 config|name-list-style=vanc}} {{Use dmy dates|date=June 2023}} {{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 457790642 | drug_name = | type = | IUPAC_name = [[Polyhedral symbol|(''SP''-4-2)]]-diamminedichloridoplatinum(II) | image = CisplatinTR.svg | image_class = skin-invert-image | alt = | caption = | imageL = Cisplatin-3D-balls.png | image_classL = bg-transparent | widthL = 140 | imageR = Cisplatin-3D-vdW.png | image_classR = bg-transparent <!--Clinical data-->| tradename = Platinol, others | synonyms = Cisplatinum, platamin, neoplatin, cismaplat, ''cis''-diamminedichloroplatinum(II) (CDDP) | Drugs.com = {{drugs.com|monograph|cisplatin}} | MedlinePlus = a684036 | licence_EU = | licence_US = | DailyMedID = Cisplatin | pregnancy_AU = D | pregnancy_AU_comment = <ref name="Drugs.com pregnancy">{{cite web | title=Cisplatin Use During Pregnancy | website=Drugs.com | date=12 September 2019 | url=https://www.drugs.com/pregnancy/cisplatin.html | access-date=25 February 2020}}</ref> | pregnancy_US = N | pregnancy_US_comment = <ref name="Drugs.com pregnancy" /> | pregnancy_category = Contraindicated<ref name="Drugs.com pregnancy" /> | legal_AU = S4 | legal_CA = Rx-only | legal_UK = POM | legal_US = Rx-only | legal_status = | routes_of_administration = [[Intravenous therapy|Intravenous]] | ATC_prefix = L01 | ATC_suffix = XA01 <!--Pharmacokinetic data-->| bioavailability = 100% (IV) | protein_bound = > 95% | metabolism = | elimination_half-life = 30–100 hours | excretion = Renal <!--Identifiers-->| CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 15663-27-1 <!-- verified against list from Chemical Abstracts Service --> | PubChem = 2767 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00515 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = 76401 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = Q20Q21Q62J | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D00275 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 27899 | ChEMBL_Ref = {{ebicite|changed|EBI}} | ChEMBL = 2068237 | PDB_ligand = CPT <!--Chemical data-->| chemical_formula = [Pt(NH<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>] | N = 2 | H = 6 | Cl = 2 | Pt = 1 | smiles = [NH3+][Pt+2](Cl)(Cl)[NH3+] | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = LXZZYRPGZAFOLE-UHFFFAOYSA-L }} <!-- Definition and medical uses --> '''Cisplatin''' is a chemical compound with [[chemical formula|formula]] ''cis''-{{chem2|[Pt(NH3)2Cl2]}}. It is a [[coordination complex]] of [[platinum]] that is used as a [[chemotherapy medication]] used to treat a number of [[cancers]].<ref name=AHFS2016/> These include [[testicular cancer]], [[ovarian cancer]], [[cervical cancer]], [[bladder cancer]], [[head and neck cancer]], [[esophageal cancer]], [[lung cancer]], [[mesothelioma]], [[brain tumors]] and [[neuroblastoma]].<ref name=AHFS2016/> It is given by [[intravenous|injection into a vein]].<ref name=AHFS2016/> <!-- Side effects and mechanisms --> Common side effects include [[bone marrow suppression]], [[hearing problems]] including severe hearing loss, [[nephrotoxicity|kidney damage]], and [[vomiting]].<ref name=AHFS2016/><ref>{{cite journal | vauthors = Oun R, Moussa YE, Wheate NJ | title = The side effects of platinum-based chemotherapy drugs: a review for chemists | journal = Dalton Transactions | volume = 47 | issue = 19 | pages = 6645–6653 | date = May 2018 | pmid = 29632935 | doi = 10.1039/c8dt00838h }}</ref><ref name="pmid29051464">{{cite journal |vauthors=Callejo A, Sedó-Cabezón L, Juan ID, Llorens J |title=Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies |journal=Toxics |volume=3 |issue=3 |pages=268–293 |date=July 2015 |pmid=29051464 |pmc=5606684 |doi=10.3390/toxics3030268|doi-access=free |bibcode=2015Toxic...3..268C }}</ref> Other serious side effects include numbness, trouble walking, [[allergic reactions]], [[electrolyte problems]], and [[heart disease]].<ref name=AHFS2016/> Use during pregnancy can cause harm to the developing fetus.<ref name="Drugs.com pregnancy" /><ref name=AHFS2016/> Cisplatin is in the [[platinum-based antineoplastic]] family of medications.<ref name=AHFS2016/> It works in part by binding to DNA and inhibiting [[DNA replication|its replication]].<ref name=AHFS2016/> <!-- History and culture --> Cisplatin was first reported in 1845 and licensed for medical use in 1978 and 1979.<ref name=Fis2006>{{cite book | vauthors = Fischer J, Ganellin CR |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495|page=513|url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA513 |language=en|url-status=live|archive-url=https://web.archive.org/web/20161220163817/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA513 |archive-date=20 December 2016}}</ref><ref name=AHFS2016>{{cite web |title=Cisplatin |url= https://www.drugs.com/monograph/cisplatin.html |publisher=The American Society of Health-System Pharmacists|access-date=8 December 2016|url-status=live|archive-url=https://web.archive.org/web/20161221012444/https://www.drugs.com/monograph/cisplatin.html|archive-date=21 December 2016}}</ref> It is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO21st">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 21st list 2019 | year = 2019 | hdl = 10665/325771 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO | hdl-access=free }}</ref><ref name="WHO22nd">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 22nd list (2021) | year = 2021 | hdl = 10665/345533 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2021.02 | hdl-access=free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)